This compound is a sulfonylcarbamate derivative serving as a pharmaceutical intermediate. It features a structure containing both amide and aromatic ring functionalities, making it suitable for use in chemical synthesis and pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1076198-09-8
Tetramethyl Ibandronate
Bisphosphonate intermediate for ibandronic acid synthesis
Rac N-Methyl Atomoxetine Oxalate
Pharmaceutical intermediate for atomoxetine derivative
Methyl 4-((5-amino-1-methyl-1H-indol-3-yl)methyl)-3-methoxybenzoate
pharmaceutical intermediate
6-Methoxy-1-tetralone
Intermediate for steroid synthesis
5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
pharmaceutical intermediate
N-(pyrazine-2-yl-carbonyl)-L-phenylalanine
pharmaceutical impurity reference standard
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
active pharmaceutical ingredient
N-(Pyrazinylcarbonyl)-L-phenylalanine
Pharmaceutical intermediate
ethyl N-[4-[2-[(5-methylpyrazine-2-carbonyl)amino]ethyl]phenyl]sulfonylcarbamate
IWLIZOPQUBXCKO-UHFFFAOYSA-N
CCOC(=O)NS(=O)(=O)C1=CC=C(C=C1)CCNC(=O)C2=NC=C(N=C2)C